Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Non Operating Income (2022 - 2025)

Gossamer Bio's Non Operating Income history spans 4 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 286.79% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached $270000.0, down 96.52%, while the annual FY2025 figure was $270000.0, 93.7% down from the prior year.
  • Non Operating Income reached -$1.3 million in Q4 2025 per GOSS's latest filing, down from $893000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.5 million in Q2 2023 to a low of -$7.7 million in Q4 2023.
  • Average Non Operating Income over 4 years is $73875.0, with a median of $332000.0 recorded in 2025.
  • Peak YoY movement for Non Operating Income: crashed 447.69% in 2023, then soared 454.84% in 2025.
  • A 4-year view of Non Operating Income shows it stood at -$1.4 million in 2022, then plummeted by 447.69% to -$7.7 million in 2023, then soared by 108.94% to $689000.0 in 2024, then tumbled by 286.79% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Non Operating Income are -$1.3 million (Q4 2025), $893000.0 (Q3 2025), and $492000.0 (Q2 2025).